170 related articles for article (PubMed ID: 28826049)
21. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and safety of the combined therapy of valproic acid and lamotrigine for epileptics].
Kang HC; Hu Q; Liu XY; Xu F; Li X; Liu ZG; Zeng Z; Wang M; Zhu SQ
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1174-8. PubMed ID: 22883004
[TBL] [Abstract][Full Text] [Related]
24. Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy.
Pipek LZ; Pipek HZ; Castro LHM
Sci Rep; 2022 Jul; 12(1):12350. PubMed ID: 35854146
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
26. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
Sidhu HS; Srinivas R; Sadhotra A
Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
28. Lamotrigine in treatment of 120 children with epilepsy.
Schlumberger E; Chavez F; Palacios L; Rey E; Pajot N; Dulac O
Epilepsia; 1994; 35(2):359-67. PubMed ID: 8156958
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness analysis of three-drug combination therapies for refractory focal epilepsy.
Wu C; Wu H; Zhou Y; Liu X; Huang S; Zhu S
Neurotherapeutics; 2024 Apr; 21(3):e00345. PubMed ID: 38490875
[TBL] [Abstract][Full Text] [Related]
30. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy].
Juryńczyk J; Weglewski A
Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903
[TBL] [Abstract][Full Text] [Related]
31. Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage?
Morris RG; Black AB; Lam E; Westley IS
Ther Drug Monit; 2000 Dec; 22(6):656-60. PubMed ID: 11128232
[TBL] [Abstract][Full Text] [Related]
32. Chronic management of seizures in the syndromes of idiopathic generalized epilepsy.
Bourgeois BF
Epilepsia; 2003; 44 Suppl 2():27-32. PubMed ID: 12752459
[TBL] [Abstract][Full Text] [Related]
33. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
[TBL] [Abstract][Full Text] [Related]
34. Lamotrigine XR conversion to monotherapy: first study using a historical control group.
French JA; Temkin NR; Shneker BF; Hammer AE; Caldwell PT; Messenheimer JA
Neurotherapeutics; 2012 Jan; 9(1):176-84. PubMed ID: 22139591
[TBL] [Abstract][Full Text] [Related]
35. [The use of lamotrigine in female patients].
Schmitz B; Bergmann L
Nervenarzt; 2007 Aug; 78(8):912-22. PubMed ID: 16523355
[TBL] [Abstract][Full Text] [Related]
36. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
[TBL] [Abstract][Full Text] [Related]
37. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
[TBL] [Abstract][Full Text] [Related]
38. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
39. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
40. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
